← Back to Search

Device

WFMA - wireless floating microelectrode array for Eye Injury (ICVP Trial)

N/A
Waitlist Available
Led By Philip R Troyk, PhD
Research Sponsored by Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from two-weeks post-op to end of device use, up to 3 years.
Awards & highlights

ICVP Trial Summary

This trial will test if it's possible to create artificial vision in people who are blind by implanting electrical stimulator in their brains.

Eligible Conditions
  • Blindness
  • Eye Injury
  • Age-Related Macular Degeneration
  • Optic Neuropathy

ICVP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from two-weeks post-op to end of device use, up to 3 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from two-weeks post-op to end of device use, up to 3 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To test the safety of the WFMA-based cortical interface.
Secondary outcome measures
To test the efficacy of the WFMA-based cortical interface

ICVP Trial Design

1Treatment groups
Experimental Treatment
Group I: WFMA Cortical Visual Prosthesis Single-arm StudyExperimental Treatment1 Intervention
The WFMA is an electronic device that is implanted in the cortical vision processing regions of the brain to produce artificial vision.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterOTHER
422 Previous Clinical Trials
163,526 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,256 Previous Clinical Trials
14,820,066 Total Patients Enrolled
University of ChicagoOTHER
1,001 Previous Clinical Trials
817,725 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for volunteers in this experiment?

"Yes, the database of clinicaltrials.gov attests that this trial is currently searching for volunteers. The study was first published on August 20th 2020 and was modified most recently in January 9th 2022. Five participants are needed from a single site to fulfill its requirements."

Answered by AI

Who is eligible to participate in this medical trial?

"This study is searching for 5 willing participants aged 19 to 70 with a history of optic nerve disease. To participate, candidates must have experienced normal or near-normal visual acuity during their first decade and blindness thereafter, as well possess the capability to attend all follow up sessions while having access to transportation assistance. Additionally, they need to be motivated by altruism and willing to record audio/video footage according to pre screening consent forms. They should also demonstrate cognitive & spatial aptitude without relying on light perception or bare light perception in either eye (as indicated per ICD 10 CM codes) and benefit from supportive family members/friends."

Answered by AI

How many participants are actively involved in this clinical trial?

"Indeed, available on clinicaltrials.gov is the information that this medical study has opened recruiting to participants since August 20th 2020 and was most recently updated January 9th 2022. The researchers are hoping to find 5 patients at a single site."

Answered by AI

Is the sample population for this research limited to individuals over twenty years of age?

"This medical experiment is open to individuals who are aged 19 or over and 70 or under."

Answered by AI
~1 spots leftby Apr 2025